• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童哮喘中的嗜酸性粒细胞衍生神经毒素:与疾病严重程度的相关性。

Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity.

作者信息

Kim Chang-Keun, Callaway Zak, Fletcher Rachel, Koh Young Yull

机构信息

Asthma and Allergy Center, Department of Pediatrics, Inje University Sanggye Paik Hospital, Seoul, Korea.

出版信息

J Asthma. 2010 Jun;47(5):568-73. doi: 10.3109/02770901003792833.

DOI:10.3109/02770901003792833
PMID:20560830
Abstract

BACKGROUND

Eosinophil numbers and eosinophil cationic protein (ECP) levels have been proposed as markers of disease activity; however, the usefulness of eosinophil-derived neurotoxin (EDN)--another eosinophil granular protein--as a marker in pediatric asthma has not been established.

OBJECTIVE

The authors compared the concentrations of blood eosinophil counts (TECs), serum ECP, and serum EDN to asthma symptom severity in young children.

METHODS

Forty-three young children with asthma (Asthma group: mean age, 2.9 years; range, 1.4-5.0 years) were evaluated during both the acute and stable phases of disease. Asthma severity was measured using a symptom-scoring technique, and serum eosinophil indices (EDN and ECP levels and TECs) were determined. Nineteen age-matched controls (Control group: mean age, 2.7 years; range, 1.0-5.0 years) were used for comparison.

RESULTS

Levels of serum EDN, serum ECP, and TECs were significantly higher in children with acute asthma compared with Controls (p < .0001). However, in stable asthma only EDN and ECP levels differed significantly when compared to Controls (p < .0001 and p < .001, respectively). When comparing acute and stable phases, EDN and TECs differed significantly (p < .0001), whereas ECP did not. Symptom scores correlated significantly with EDN (r = 0.850, p < 0.0001), ECP (r = 0.374, p < 0.01) and TECs (r = 0.457, p < 0.01) in acute asthma patients. When symptom scores were divided into three subgroups based on severity, only EDN levels showed significant differences amongst the three groups.

CONCLUSION

These findings suggest that serum EDN is a useful marker for identifying disease activity in children with asthma. EDN levels may better reflect disease severity than ECP levels or total eosinophil counts.

摘要

背景

嗜酸性粒细胞数量和嗜酸性粒细胞阳离子蛋白(ECP)水平已被提议作为疾病活动的标志物;然而,嗜酸性粒细胞衍生神经毒素(EDN)——另一种嗜酸性粒细胞颗粒蛋白——作为小儿哮喘标志物的效用尚未确立。

目的

作者比较了幼儿血液嗜酸性粒细胞计数(TECs)、血清ECP和血清EDN浓度与哮喘症状严重程度的关系。

方法

对43名患有哮喘的幼儿(哮喘组:平均年龄2.9岁;范围1.4 - 5.0岁)在疾病的急性期和稳定期进行评估。使用症状评分技术测量哮喘严重程度,并测定血清嗜酸性粒细胞指标(EDN和ECP水平以及TECs)。选取19名年龄匹配的对照儿童(对照组:平均年龄2.7岁;范围1.0 - 5.0岁)进行比较。

结果

与对照组相比,急性哮喘患儿的血清EDN、血清ECP和TECs水平显著更高(p < .0001)。然而,在稳定期哮喘中,与对照组相比仅EDN和ECP水平有显著差异(分别为p < .0001和p < .001)。比较急性期和稳定期时,EDN和TECs有显著差异(p < .0001),而ECP没有。在急性哮喘患者中,症状评分与EDN(r = 0.850,p < 0.0001)、ECP(r = 0.374,p < 0.01)和TECs(r = 0.457,p < 0.01)显著相关。当根据严重程度将症状评分分为三个亚组时,只有EDN水平在三组之间显示出显著差异。

结论

这些发现表明血清EDN是识别哮喘患儿疾病活动的有用标志物。EDN水平可能比ECP水平或嗜酸性粒细胞总数更能反映疾病严重程度。

相似文献

1
Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity.儿童哮喘中的嗜酸性粒细胞衍生神经毒素:与疾病严重程度的相关性。
J Asthma. 2010 Jun;47(5):568-73. doi: 10.3109/02770901003792833.
2
Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma.血清嗜酸性粒细胞衍生神经毒素(EDN)在儿童哮喘的诊断、严重程度评估及支气管高反应性评估中的应用
Lung. 2007 Mar-Apr;185(2):97-103. doi: 10.1007/s00408-006-0054-8. Epub 2007 Mar 28.
3
Eosinophilic cationic protein: is it useful in assessing control of childhood asthma?嗜酸性粒细胞阳离子蛋白:在评估儿童哮喘控制中是否有用?
East Mediterr Health J. 2010 Oct;16(10):1045-9.
4
Serum eosinophil cationic protein as a predictor of disease activity in acute and chronic asthma.血清嗜酸性粒细胞阳离子蛋白作为急性和慢性哮喘疾病活动的预测指标。
East Afr Med J. 1999 Sep;76(9):524-9.
5
Correlation of eosinophil cationic protein with severity of asthma.嗜酸性粒细胞阳离子蛋白与哮喘严重程度的相关性。
J Ayub Med Coll Abbottabad. 2004 Jul-Sep;16(3):66-71.
6
The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.孟鲁司特治疗对哮喘儿童血清白细胞介素-10水平、嗜酸性粒细胞阳离子蛋白、血液嗜酸性粒细胞计数及临床参数的影响。
Turk J Pediatr. 2009 Sep-Oct;51(5):460-5.
7
Significance of the eosinophil cationic protein/eosinophil count ratio in asthmatic patients: its relationship to disease severity.嗜酸性粒细胞阳离子蛋白/嗜酸性粒细胞计数比值在哮喘患者中的意义:其与疾病严重程度的关系。
Ann Allergy Asthma Immunol. 2001 Mar;86(3):323-9. doi: 10.1016/S1081-1206(10)63307-8.
8
Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.用于监测儿童哮喘临床病程的血液、血清和尿液中的嗜酸性粒细胞标志物:布地奈德治疗及撤药的影响
J Allergy Clin Immunol. 2001 May;107(5):812-7. doi: 10.1067/mai.2001.114246.
9
Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.白细胞介素-16、巨噬细胞衍生趋化因子、嗜酸性粒细胞阳离子蛋白及可溶性E选择素在反映特应性皮炎疾病活动度中的意义——从实验室指标到临床评分
Br J Dermatol. 2006 Jun;154(6):1112-7. doi: 10.1111/j.1365-2133.2006.07201.x.
10
Serum eosinophil-derived neurotoxin: correlation with persistent airflow limitation in adults with house-dust mite allergic asthma.血清嗜酸性粒细胞衍生神经毒素:与屋尘螨过敏性哮喘成人患者持续性气流受限的相关性
Allergy Asthma Proc. 2015 Nov-Dec;36(6):e113-20. doi: 10.2500/aap.2015.36.3884.

引用本文的文献

1
Serum and nasal lavage fluid eosinophil-derived neurotoxin levels and their determinants in adults.成人血清和鼻腔灌洗液中嗜酸性粒细胞衍生神经毒素水平及其决定因素
J Allergy Clin Immunol Glob. 2025 Jun 6;4(3):100510. doi: 10.1016/j.jacig.2025.100510. eCollection 2025 Aug.
2
Eosinophil-derived neurotoxin levels can predict allergic disease development and atopic march in children.嗜酸性粒细胞衍生神经毒素水平可预测儿童过敏性疾病的发展及特应性进程。
Clin Exp Pediatr. 2025 Jun;68(6):398-405. doi: 10.3345/cep.2024.01382. Epub 2025 Feb 3.
3
Serum and urine eosinophil-derived neurotoxin (EDN) levels predict biologic response in severe asthma.
血清和尿液嗜酸性粒细胞衍生神经毒素(EDN)水平可预测重度哮喘的生物学反应。
World Allergy Organ J. 2025 Jan 9;18(1):100990. doi: 10.1016/j.waojou.2024.100990. eCollection 2025 Jan.
4
Efficacy and Safety of Montelukast+Levocetirizine Combination Therapy Compared to Montelukast Monotherapy for Allergic Rhinitis in Children.孟鲁司特+左西替利嗪联合治疗与孟鲁司特单药治疗儿童过敏性鼻炎的疗效及安全性比较
Allergy Asthma Immunol Res. 2024 Nov;16(6):652-667. doi: 10.4168/aair.2024.16.6.652.
5
Utility of eosinophil granule proteins in management of pediatric chronic cough.嗜酸性粒细胞颗粒蛋白在儿童慢性咳嗽管理中的应用
Clin Exp Pediatr. 2024 Oct;67(10):519-520. doi: 10.3345/cep.2023.01431. Epub 2024 Apr 17.
6
Biomarkers in allergen immunotherapy: Focus on eosinophilic inflammation.变应原免疫治疗中的生物标志物:聚焦嗜酸性粒细胞炎症。
Asia Pac Allergy. 2024 Mar;14(1):32-38. doi: 10.5415/apallergy.0000000000000129. Epub 2023 Dec 18.
7
Natural history of eosinophil‑derived neurotoxin levels and the onset of allergic airway disease in preschool children.学龄前儿童嗜酸性粒细胞衍生神经毒素水平的自然史与过敏性气道疾病的发病
Exp Ther Med. 2023 Oct 20;26(6):565. doi: 10.3892/etm.2023.12264. eCollection 2023 Dec.
8
Eosinophil granule proteins as a biomarker in managing asthma and allergies.嗜酸性粒细胞颗粒蛋白作为管理哮喘和过敏的生物标志物。
Asia Pac Allergy. 2023 Jun;13(2):66-71. doi: 10.5415/apallergy.0000000000000104. Epub 2023 Jun 13.
9
New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis.哮喘和伴或不伴鼻息肉的慢性鼻-鼻窦炎的病理生理学和治疗靶点的新见解。
Clin Sci (Lond). 2023 May 18;137(9):727-753. doi: 10.1042/CS20190281.
10
The role of human ribonuclease A family in health and diseases: A systematic review.人类核糖核酸酶A家族在健康与疾病中的作用:一项系统综述。
iScience. 2022 Oct 7;25(11):105284. doi: 10.1016/j.isci.2022.105284. eCollection 2022 Nov 18.